focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.05
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.70 (3.846%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 45.05
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Long Term Incentive Plan and PDMR Dealing

12 Dec 2023 17:50

RNS Number : 5506W
Benchmark Holdings PLC
12 December 2023

12 December 2023

Benchmark Holdings plc

("Benchmark", the "Company" or the "Group")

New Long Term Incentive Plan and PDMR Dealing

Benchmark, the aquaculture biotechnology company, today announces that the Board of Directors has agreed to establish and adopt the Benchmark Holdings Plc Long Term Incentive Plan ("New LTIP") for the senior management team following the expiry of the Company's previous LTIP at the end of its 10-year life.

The Non-Executive Directors have consulted with certain major shareholders of the Group on the New LTIP with a view to creating a simple incentive plan that aligns the potential rewards with shareholder returns and acts as an attractive scheme to retain the senior management team and incentivise shareholder value creation.

Under the terms of the New LTIP, each recipient receiving the awards made on 12 December 2023 was granted both a Restricted Shares award and Performance Shares award over ordinary shares of 0.1p each. The awards granted to PDMRs of the Company were as follows:

Director

No. of shares over which awards granted

Trond Williksen (CEO)

Restricted Shares: 1,825,420

Performance Shares: 1,216,940

Septima Maguire (CFO)

Restricted Shares: 1,244,230

Performance Shares: 829,490

The awards will ordinarily vest and become exercisable at an exercise price of 0.1p per share two years after grant subject to continued service and, for the Performance Shares, to the extent performance conditions are achieved. Participants who leave employment before vesting will lose their award, subject to certain limited 'good leaver' conditions.

Performance conditions for the Performance Shares awards

The Performance Shares awards conditions set threshold to stretch targets in respect of the Company's total shareholder return ("TSR") over the two-year period following the grant of the awards. No portion of the Performance Shares awards shall vest unless the Company's TSR over the performance period reaches the threshold target.

Absolute TSR Growth

Vesting of performance shares

Below 188%1

0%

At 188%

20%

Between 188% and 269%2

20% - 100% on a straight-line basis

At 269% or above

100%

[1] Equivalent to an end share price of 70p from a three-month average base position of 37.17p

2 Equivalent to an end share price of 100p from a three-month average base position 37.17p

The forecast maximum dilution from the New LTIP is 1.6%.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMR) AND PERSONS CLOSELY ASSOCIATED WITH THEM

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Trond Williksen

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Benchmark Holdings plc

)

LEI:

2138001UQHM4VZGXUJ19

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 0.1 pence each in the Company

ISIN: GB00BGHPT808

b)

Nature of the transaction:

Options over ordinary shares granted under the Benchmark Holdings PLC Long Term Incentive Plan with an exercise price of 0.1p per share

c)

Price(s) and volume(s):

Type

Price

Volume(s)

Ordinary shares

Nil

1,825,420

Nil

1,216,940

d)

Aggregated information:

· Aggregated volume:

·Price:

Volume: 3,042,360

e)

Date of the transaction:

12 December 2023

f)

Place of the transaction:

Outside of a trading venue

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Septima Maguire

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Benchmark Holdings plc

b)

LEI:

2138001UQHM4VZGXUJ19

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 0.1 pence each in the Company

ISIN: GB00BGHPT808

b)

Nature of the transaction:

Options over ordinary shares granted under the Benchmark Holdings PLC Long Term Incentive Plan with an exercise price of 0.1p per share

c)

Price(s) and volume(s):

Type

Price

Volume(s)

Ordinary shares

Nil

1,244,230

Nil

829,490

d)

Aggregated information:

·Aggregated volume:

·Price:

Volume: 2,073,720

e)

Date of the transaction:

12 December 2023

f)

Place of the transaction:

Outside of a trading venue

Enquiries

Benchmark Holdings plc

Tel: 0114 240 9939

Trond Williksen, CEO

Septima Maguire, CFO

Ivonne Cantu, Investor Relations

?

Deutsche Numis (Broker and NOMAD)

Tel: 020 7260 1000

Freddie Barnfield, Duncan Monteith, Sher Shah

MHP

Tel: 020 3128 8004

Katie Hunt, Reg Hoare

benchmark@mhpgroup.com

About Benchmark

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability. We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out. Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFSDFELFLIV
Date   Source Headline
11th Sep 20205:58 pmRNSHolding(s) in Company
10th Sep 20209:15 amRNSPositive Opinion from the EMA on BMK08
4th Sep 20207:00 amRNSDirector/PDMR Shareholding
28th Aug 20207:00 amRNSTotal Voting Rights
28th Aug 20207:00 amRNSQ3 Results
21st Aug 20207:00 amRNSNotice of Q3 Results
31st Jul 202011:17 amRNSCompletion of sale of vaccine facility
31st Jul 20207:00 amRNSTotal Voting Rights
23rd Jul 202011:05 amRNSSale of vaccine manufacturing assets
1st Jul 20207:00 amRNSSale of FishVet
30th Jun 20207:00 amRNSTotal Voting Rights
23rd Jun 20207:00 amRNSSale of Improve International
8th Jun 20204:54 pmRNSDirector/PDMR Shareholding - Replacement
8th Jun 202010:43 amRNSDirector/PDMR Shareholding
5th Jun 20205:50 pmRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
29th May 20207:00 amRNSSecond Quarter and Interim Results
27th May 20208:30 amRNSEquity Development Results Webinar
19th May 20207:00 amRNSNotice of Q2 and Interim Results
6th May 202012:09 pmRNSHolding(s) in Company
30th Apr 20207:00 amRNSTotal Voting Rights
21st Apr 20207:00 amRNSDirector and Divisional Management Changes
7th Apr 20207:00 amRNSAppointment of Chief Executive Officer
2nd Apr 20207:00 amRNSCovid-19 update
31st Mar 202011:12 amRNSTotal Voting Rights
20th Mar 20207:00 amRNSBlock Listing Six Monthly Review
18th Mar 20207:00 amRNSBlock Admission Application
16th Mar 202012:00 pmRNSDirector Dealings
12th Mar 20201:15 pmRNSResult of AGM
9th Mar 20202:01 pmRNSHolding(s) in Company
9th Mar 20201:46 pmRNSDIRECTOR DEALINGS
28th Feb 20207:00 amRNSTotal Voting Rights
28th Feb 20207:00 amRNSQ1 Results
25th Feb 20209:43 amRNSDIRECTOR SHARE OPTIONS
21st Feb 202010:49 amRNSDirector/PDMR Shareholding
20th Feb 20204:10 pmRNSHolding(s) in Company
20th Feb 20209:15 amRNSHolding(s) in Company
17th Feb 20204:28 pmRNSResult of General Meeting and Total Voting Rights
17th Feb 20207:00 amRNSResult of Open Offer
11th Feb 20207:00 amRNSPosting of Annual Report & Accounts &Notice of AGM
31st Jan 20207:00 amRNSTotal Voting Rights
30th Jan 20202:46 pmRNSTimetable for Placing and Open Offer
30th Jan 20207:00 amRNSPlacing and Open Offer
31st Dec 20197:00 amRNSTotal Voting Rights
20th Dec 20199:06 amRNSSecond Price Monitoring Extn
20th Dec 20199:00 amRNSPrice Monitoring Extension
20th Dec 20197:00 amRNSQ4 Results
20th Dec 20197:00 amRNSFull Year Results
4th Dec 20197:00 amRNSDirectorate Change
29th Nov 20197:00 amRNSQ4 and FY Trading Update & Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.